The Recombinant DNA Advisory Committee, a division of the National Institutes of Health that approves all gene therapy experiments, has yet to make a decision on whether this technique should move into the clinic.

FORBES: Magazine Article

But, for all their willingness to make such experiments, the Swiss still clamp down hard on drug users and dealers.

ECONOMIST: Drugs in Switzerland

Make no mistake, society will be the better for all the experiments being tried, but expect nearly all to fail on economic grounds.

FORBES: Investing in Biofuels or Biofools?